Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications
作者:Michael C. Van Zandt、Brian Doan、Diane R. Sawicki、Janet Sredy、Alberto D. Podjarny
DOI:10.1016/j.bmcl.2009.02.037
日期:2009.4
the discovery of a novel series of highly potent and selective [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid aldose reductase inhibitors. The lead candidate, [6-methyl-3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acid example 16, inhibits aldose reductase with an IC50 of 8 nM, while being inactive against aldehyde reductase (IC50 > 100 μM)
确定慢性糖尿病并发症的治疗方法的努力导致发现了一系列新的高效和选择性的[3-(4,5,7-三氟-苯并噻唑-2-基甲基)-吡咯并[2,3- b ]吡啶-1-基]乙酸醛糖还原酶抑制剂。主要候选化合物[6-甲基-3-(4,5,7-三氟-苯并噻唑-2-基甲基)-吡咯并[2,3 - b ]吡啶-1-基]乙酸实例16,抑制醛糖还原酶IC50为8 nM,而对醛还原酶(IC50> 100μM)无活性,醛还原酶是一种与活性醛解毒有关的相关酶。